CRP and COVID-19: Moreover, in the group of ASA-treated COVID-19 patients, in-hospital < 30 days all-cause mortality was more frequently observed in patients showing higher C-reactive protein levels upon admission (C-reactive protein upon admission (mg/L): ASA-treated < 30 days dead patients: 139.02 ± 26.12; discharged patients: 83.73 ± 16.11, p = 0.033).